YTEN News and Press, Yield10 Bioscience Inc. From 10/06/22

WOBURN, MA / ACCESSWIRE / October 6, 2022 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the MicroCap Rodeo presents: The Windy City Roundup 2022 investor conference, which is being held in-person on O...

WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that Willie Loh, Ph.D., was named to the Company’s Board of Directors effective Octobe...

WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the International Sympos...

WOBURN, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the ...

Yield10 Bioscience, Inc. (YTEN) Q2 2022 Earnings Conference Call August 10, 2022, 16:30 ET Company Participants Lynne Brum - VP, Planning & Corporate Communications & Secretary Oliver Peoples - Co-Founder, President, CEO & Director Kristi Snell - VP, ...

The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Yield10 Bioscience, Inc. 2022 Q2 - Results - Earnings Call Presentation

Yield10 Bioscience press release ( NASDAQ: YTEN ): Q2 GAAP EPS of $0.70 beats by $1.39 . Revenue of $0.1M (-41.2% Y/Y) misses by $0.06M . For further details see: Yield10 Bioscience GAAP EPS of $0.70 beats by $1.39, revenue of $0.1M misses by $0.06M

-Winter program targeting more than 1,000 acres through grower contracts -On track to achieve key 2022 goal of identifying herbicide tolerant Camelina lines for seed scale up and commercial development -Management will host a conference call today at 4:30 p.m. (ET)...

WOBURN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2022 financial results and provide a corporat...

WOBURN, Mass. and SASKATOON, Saskatchewan, July 12, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10 Bioscience” or the “Company”), an agricultural bioscience company, today announced the name change of its wholly-owned Canadian subsidiar...